ClearNote Health to Showcase Industry-Leading Early Detection Performance of the Avantect® Pancreatic Cancer Test at AACR Annual Meeting 2026

SAN DIEGO — April 15, 2026 — ClearNote Health, a company dedicated to improving early detection for some of the deadliest cancers, today announced a lineup of presentations at the upcoming annual meeting of the American Association for Cancer Research (AACR) in San Diego, taking place April 17-22. Attendees at the AACR Annual Meeting 2026 can meet with ClearNote Health’s scientific leaders, including newly appointed Chief Medical Officer, Jeffrey Venstrom, MD. At booth 3448, the company will showcase its Virtuoso™ epigenomics platform for drug development, as well […] The post ClearNote Health